GTBP
GT Biopharma Inc
NASDAQ: GTBP · HEALTHCARE · BIOTECHNOLOGY
$0.31
+13.31% today
Updated 2026-04-30
Market cap
$8.83M
P/E ratio
—
P/S ratio
204.96x
EPS (TTM)
$-6.68
Dividend yield
—
52W range
$0 – $4
Volume
0.7M
GT Biopharma Inc (GTBP) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-1,377.00%
ROA
-125.80%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $5.78M | $-4.94M | 46.61% | -46.23% | -85.53% |
| 2007 | $6.05M | $471000.00 | 46.09% | -18.45% | 7.79% |
| 2008 | $1.14M | $-5.01M | 20.47% | -105.95% | -437.97% |
| 2009 | $48000.00 | $-2.25M | -4.17% | -2,408.33% | -4,679.17% |
| 2010 | $11000.00 | $-3.00M | -490.91% | -22,700.00% | -27,227.27% |
| 2011 | $26000.00 | $-3.70M | -84.62% | -15,107.69% | -14,230.77% |
| 2012 | $342000.00 | $-5.17M | 72.51% | -1,027.49% | -1,511.99% |
| 2013 | $368000.00 | $-501000.00 | 38.59% | -215.49% | -136.14% |
| 2014 | $61000.00 | $-23.49M | 6.56% | -3,927.87% | -38,506.56% |
| 2015 | $27000.00 | $-21.46M | 92.59% | -33,062.96% | -79,485.19% |
| 2016 | $0.00 | $9.77M | — | — | — |
| 2017 | $27000.00 | $-144.17M | -7.41% | -502,111.11% | -533,970.37% |
| 2018 | $0.00 | $-259.19M | — | — | — |
| 2019 | $0.00 | $-38.65M | — | — | — |
| 2020 | $0.00 | $-28.30M | — | — | — |
| 2021 | $0.00 | $-58.01M | — | — | — |
| 2022 | $0.00 | $-20.88M | — | — | — |
| 2023 | $0.00 | $-7.60M | — | — | — |
| 2024 | $0.00 | $-13.16M | — | — | — |
| 2025 | $0.00 | $-28.35M | — | — | — |